Bio Rad Laboratories Inc (NYSE:BIO)

BATS BZX Real-Time Price
As of 11:51am ET
 +2.76 / +1.88%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

Bio-Rad Laboratories, Inc. is engaged in the development and production of specialty chemicals used in biochemical, pharmaceutical and other life science research applications. It manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify its components. The company operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment is at the forefront of discovery, creating advanced tools to answer complex biological questions. Its products are used in established research techniques, biopharmaceutical production processes and food testing regimes. These techniques are typically used to separate, purify and identify biological materials such as proteins, nucleic acids and bacteria within a laboratory or production setting. This segment focuses on selected segments of the life sciences market in proteomics the study of proteins, genomics the study of genes, biopharmaceutical production, and cell biology and food safety. The Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialize in quality controls that serve clinical laboratories in the global diagnostics market. Its products currently address specific niches within the in vitro diagnostics test market, and the company focuses on the higher margin, higher growth segments of this market. IVD tests are conducted outside the human body and are used to identify and measure substances in a patient's tissue, blood or urine. Bio-Rad Laboratories was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Contact Information

Bio-Rad Laboratories, Inc.
1000 Alfred Nobel Drive
Hercules California 94547
P:(510) 724-7000
Investor Relations:



Other institutional39.98%
Mutual fund holders39.40%
Individual stakeholders26.96%

Top Executives

Norman D. SchwartzChairman, President & Chief Executive Officer
John GoetzChief Operating Officer
Christine A. TsingosCFO, Executive VP & Head-Investor Relations
John HertiaEVP & President-Clinical Diagnostics Group
Shannon HallExecutive VP & President-Life Science Group

To view my watchlist

Not a member yet?

Sign up now for a free account